Lionco Pharmaceutical Group Co.,Ltd.
SHH: 603669.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ling Ping Tao
- Employees
- 436
- Headquarters
- Shannan, China
- IPO year
- 2015
- Market cap
- CN¥3.2B
- Website
- https://www.lingkang.com.cn
Loading 603669…
Loading profile data…Frequently asked questions about 603669
What does Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) do?
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. It also operates research institutes that specialize in the research of chemi...
Where does 603669.SS trade?
Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) trades on the Shanghai Stock Exchange.
What sector is 603669.SS in?
Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Lionco Pharmaceutical Group Co.,Ltd.?
Ling Ping Tao is the chief executive officer of Lionco Pharmaceutical Group Co.,Ltd. (603669.SS).
Where is Lionco Pharmaceutical Group Co.,Ltd. headquartered?
Lionco Pharmaceutical Group Co.,Ltd. is headquartered in China.
Does 603669.SS pay a dividend?
Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 603669.SS go public?
Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) completed its initial public offering in 2015.